Jump to content
  • Announcements

    • Bodine van Wingerden


      Per 23-3-2018 the ISBT Forum is temporarily closed. We are in the process of setting up a new forum within the MyISBT section of the ISBT website. We are happy to welcome you back on the new ISBT Forum soon. Please check your email for an update once the new Forum is available. Thank you for your understanding.

      Best wishes Team ISBT

All Activity

This stream auto-updates     

  1. Earlier
  2. Haemovigilance and IVIG

    I would like to know if other countries report adverse reactions to fractionated products? in particular adverse reaction to IVIG
  3. Vacancy for chair and secretary

    Dear members of the working party Donors & Donation of the ISBT, Our secretary Matt Granato has changed job and the function secretary is available, some of you already had interest last year. The term as chair of Lee Cheuk Kwong and me will end this year. Therefore, we have elections for both the chair and the secretary. Those who already had interest in secretary can confirm that or can have an option for chair. We want to transfer and install the new chair and secretary during the ISBT in Toronto. If you have interest in the role of chair or secretary: - express you interest accompanied with a CV (maximal 1 A4) to me - reply before March 15 2018, I will forward the applications to the ISBT office - After March 15 the ISBT will have a poll - New chair and secretary elected before the ISBT Toronto. I trust in your responses and will handle with confidence. Also on halve of Lee and Matt, Peter Peter J.M. van den Burg, MD, PhD, Department Transfusion Medicine Sanquin Plesmanlaan 125 1066 CX Amsterdam The Netherlands www.sanquin.nl Chair EBA working party Education & Training http://www.europeanbloodalliance.eu/ Chair ISBT working party Donors & Donation www.ISBT.org Donor Health Care (DoHeCa) www.donorhealthcare.org
  4. Going to Toronto?

    Dear Young Investigators, Are you thinking about going to the Toronto Congress this year? In June ISBT will once again organise an International Congress on blood transfusion and transfusion medicine. The deadline for submitting your abstract is February 22, just over one month away. The main requirements for submitting your abstracts are that it should be on a topic related to transfusion medicine, you should be under 35 years of age (40 if you are applying for the Harold Gunson Fellowship, more information also in this post), and the first, submitting, and presenting author of your abstract. Find out more on the Toronto website! When you submit your abstract you can also apply for the Harold Gunson Fellowship, a travel grant that will cover your travel, hotel and registration costs. If you want to know more about applying for the Harold Gunson Fellowship you can find more information about submitting your abstract on the congress website. In Toronto another Young Investigators Breakfast will be organised where you can network with professionals in your field. Some of you have attended the breakfast meeting at past ISBT congresses, feel free to share your experience so fellow young researchers know what they can gain from this meeting. At the 34th International Congress in 2016, ISBT introduced the Young Investigator Session. In this scientific session we gave Young Investigators the opportunity to present their transfusion medicine research in an oral presentation. If you would like to apply for this session you can tick the 'Young Investigator'-box when you submit your abstract for the congress. Note; the deadline for submitting your abstract is February 22, 2018. Look around this forum for tips on writing your abstract and presenting it. How often have you submitted an abstract to a transfusion medicine congress?
  5. A few thoughts on academic writing

    Hi Gloria, Thank you for sharing your thoughts and your experience from the workshop! If you look at the ISBT abstract submission guidelines (http://isbtweb.org/fileadmin/user_upload/ISBT_Toronto_Abstract_Guidelines.pdf) you will see the requirements set by ISBT for submitted abstracts to our congresses. Reviewers look at the proper structure of the abstract, the presence of data, and the use of correct, understandable English. Please note, it is not required to use very sophisticated language at all! Actually, papers are expected to be written in such a correct, understandable manner that even people who are not experts in that field are able to understand the research. If you feel you need more help before you submit your abstract to an ISBT congress, we do offer help with reviewing your abstract (see the abstract submission guidelines, under HELP OR REVIEW OF THE STRUCTURE AND LANGUAGE OF YOUR ABSTRACT). Good luck!
  6. A few thoughts on academic writing

    I went to the one on writing scientific paper in Guangzhou, just some thoughts to share, I am still practicing with it’s stra and we’ll see how it goes. the presentation gave an idea of writing the material and method first (which I also found this part to be the easiest to write, because everything should be set and done), and then you continue to write results, with results in sum first and the specified each interesting subclasses, then you go on to discussion, where you write the ups and downs of your research and how it is comparing to others, and further research that maybe build upon this one; lastly, you went back to background to give nice introduction and make sure it does not overlap with the discussion. Oh, and when all is finished, you write the abstract. I am currently working on one, and I would say the difficulty run deeper for a non-English speaker, where I use the most common and simple words and have much less vocabulary and poor structure of the sentence. Kind of feel bad for the reviewers who revise my manuscript
  7. Hello! I am new here, that`s the reason why i am answering to you a bit late. In our country, Uruguay, we do not deffer donors if they have been vaccinated with hepatits B o Cholera. Fernanda.
  8. Titles and qualifications

    In Sri Lanka, 1. Blood grouping, antibody screening and red cell phenotyping can be done by Blood Bank Medical Officers (a medical doctor) or a Medical Laboratory Technologist. Cross match of blood can only be done by Blood Bank Medical Officers (a medical doctor) 2. Medical Officer - Blood Bank Medical Laboratory Technologist
  9. How to use clinical audit to improve PBM

    Hi John That is a wonderful offer :-) Cheers Linley
  10. TP names or alternatives: what function title do you use?

    In the United States, PhD scientists can run, if properly credentialed, infectious disease testing laboratories and histocompatibility laboratories, but cannot, in general, be directors of hospital transfusion services or hematology laboratories. There are exceptions but these are uncommon.
  11. TP names or alternatives: what function title do you use?

    Parallel terminology for other professions would be Transfusion Medicine Nurse (or Apheresis Nurse) or Nurse Co-ordinator (for patient blood management programs) and Transfusion Medicine/Blood Bank Medical Technologist (for medical technical staff, who are often licensed in the USA).
  12. TP names or alternatives: what function title do you use?

    HI Elena and Neil The term Transfusion Medicine Physician is good for those with medical qualifications. In Australia, we would not be able to use this term for nurses or scientist who are the ones who undertake the TP activities. I understand that in different countries there are physicians, medical/ anaesthetic technologist that may do these activities. The TP forum steering committee will be conducting a survey in the coming month to find out exactly what roles are around, and who fills them so we look forward to your input in the survey.
  13. TP names or alternatives: what function title do you use?

    Transfusion Medicine Physician sounds perfect!
  14. TP names or alternatives: what function title do you use?

    How about "Transfusion Medicine Physician?" In the USA, pathologist and blood banker (for both physicians and medical technologists) are used most often, which tends to (1) mislead the public and other practitioners since what pathologists are thought to do is primarily anatomic pathology (autopsy, surgical pathology, etc.) and (2) blood banker sounds like we should have an ATM, rather than a consultant clinical service :). Many transfusion service physicians (particularly outside the USA) are hematologists (or haematologists) by training. I've often used the expression "laboratory based hematologist focusing on blood transfusion" to describe what I do, but it's a mouthful.
  15. Indeed, while long stored red cells (hard to define) clearly are somewhat more toxic than medium duration stored red cells, shorter storage red cells actually are more dangerous to the extent that they mediate a higher rate of nosocomial infection in recipients. So not only are fresher red cells not better, they appear to be worse in some respects. This is the abstract reference reporting preliminary data confirming this finding, and proposing a mechanism that may contribute, namely, abnormal oxidation/reduction potential in freshly collected red cells: "Fresher blood is associated with higher oxidation reduction potential and increased risk of infection in critically ill adults. Transfusion 57 (Supplement S3): 33A (2017). To be presented by Dr. Schmidt at the AABB in San Diego soon. Blood. 2016 Jan 28;127(4):400-10. doi: 10.1182/blood-2015-09-670950. Epub 2015 Dec 1. Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis. Alexander PE1, Barty R2, Fei Y3, Vandvik PO4, Pai M5, Siemieniuk RA6, Heddle NM7, Blumberg N8, McLeod SL9, Liu J10, Eikelboom JW7, Guyatt GH1. Author information Abstract The impact of transfusing fresher vs older red blood cells (RBCs) on patient-important outcomes remains controversial. Two recently published large trials have provided new evidence. We summarized results of randomized trials evaluating the impact of the age of transfused RBCs. We searched MEDLINE, EMBASE, CINAHL, the Cochrane Database for Systematic Reviews, and Cochrane CENTRAL for randomized controlled trials enrolling patients who were transfused fresher vs older RBCs and reported outcomes of death, adverse events, and infection. Independently and in duplicate, reviewers determined eligibility, risk of bias, and abstracted data. We conducted random effects meta-analyses and rated certainty (quality or confidence) of evidence using the GRADE approach. Of 12 trials that enrolled 5229 participants, 6 compared fresher RBCs with older RBCs and 6 compared fresher RBCs with current standard practice. There was little or no impact of fresher vs older RBCs on mortality (relative risk [RR], 1.04; 95% confidence interval [CI], 0.94-1.14; P = .45; I(2) = 0%, moderate certainty evidence) or on adverse events (RR, 1.02; 95% CI, 0.91-1.14; P = .74; I(2) = 0%, low certainty evidence). Fresher RBCs appeared to increase the risk of nosocomial infection (RR, 1.09; 95% CI, 1.00-1.18; P = .04; I(2) = 0%, risk difference 4.3%, low certainty evidence). Current evidence provides moderate certainty that use of fresher RBCs does not influence mortality, and low certainty that it does not influence adverse events but could possibly increase infection rates. The existing evidence provides no support for changing practices toward fresher RBC transfusion.
  16. Live Journal Club

    Please join ISBT on September 26 at 15:00 CET when Drs. Yazer and Seheult will discuss the WOMAN study (Lancet 2017;389:2105-2116), a randomized trial of tranexamic acid in post partum hemorrhage. This discussion will be held in the style of a journal club, and there will be the opportunity for the audience to engage with the speakers about the paper at the end of the session. Members of ISBT will receive a registration link via email.
  17. ISBT Monthly Webinar proposals for topics

    Thanks for the suggestion Torunn. Does anyone else have a request for a topic?
  18. It's time to use UHF Rfid technology for blood tracking .

    Of course, for your site is necessary design the critical area and cover the area with appropriate electromagnetic signal and use appropriate software. The scope of all studies is evaluate the process control and the clinical impact of operator ; reduce time , assumption of responsibility , information and control of activity . The reassuming method is real time localisation of the people and the products. - Release preventive information and real time communication through the operators involved on the process. - Interface with BECS or HIS to realise data on the respect of work flow adopted by the Blood Bank and Hospital. For your interest the passive RFID reading management (HF and UHF) is just one part of all architectural studies , the data are the follows: Results obtained for bags inventory , e.g. box used from collection site to processing facilities Fixed Ethernet UHF reader ,2 Antenna × near field 2W , Value MIN AVG MAX Expected tags 20 20 20 Read tags 20 20 20 Accuracy 100.0% 100.0% 100.0% time reading less that 4 seconds Results obtained for bags packing ,e.g. after processing the blood bags are checked one by one and place in a special container to the freezing room or to the hospital Desktop USB UHF reader 1 Antenna × internal far field 1W Value MIN AVG MAX Expected tags 30 30 30 Read tags 30 30 30 Accuracy 100.0% 100.0% real time reading Results obtained for mobile reader e.g. to charge or discharge fridge, box, container Mobile handheld UHF reader 2 Antenna circular polarised 1W Value MIN AVG MAX Expected tags 30 30 30 Read tags 30 30 30 Accuracy 100.0% 100.0% 100.0% .
  19. It's time to use UHF Rfid technology for blood tracking .

    Thanks for your reply. Is it possible to share the results of your stiudies ?
  20. It's time to use UHF Rfid technology for blood tracking .

    We are currently 4 pilot study in different specific steps on different work flows: Blood Bank, Stem cells laboratory, Hospital and Cell Factoring . Managing different technology like : WLAN (WLAN coverage, real-time location with accuracy from 2 to 5 meters), RFID tech ( UHF HF ) iBeacons and Bluetooth localization and GPS. We are tested different UHF tags, the cheaper solution with low cost of antenna to the 100% accuracy is to detect box from 20 to 30 Units ( Red Cells or Plasma bags ), the hardware used on the study are easily buy on Amazon ( cheaper price ) .
  21. It's time to use UHF Rfid technology for blood tracking .

    We are greatly interested in using RFID technologies to optimize w<orkflow, inventory management and reduce expiry where possible. The difficulty is to find an economical model to cover the costs inherent to the introduction of this technology. Were are looking for co-operations with the industry in order to plan aplied R&D studies in this field. Intelligent storage devices should be development much more actively.
  22. TP or haemovigilance? What is your function title?

    Hi, Following the assignment of national haemovigilance guidelines (2016) by government, the establishment of the haemovigilance sytem is in progress at national level in Turkey. Major actors of the system in hospitals are haemovigilance coordinators and haemovigilance nurses. Hospital haemovigilance coordinators are medical doctors who are responsible for transfusion centers settled in hospitals that are authorized for supplying blood components from Regional Blood Centers of Turkish Red Crescent and making immunohaemotological tests only (no blood collection except emergency situations).They work in collaboration with haemovigilance nurses who are responsible for the surveillance of all transfusions in the hospital. Regional blood centers also have haemovigilance departments for surveillance of donations and blood components delivered to hospitals. All haemovigilance data are collected by Regional haemovigilance units related to Ministry of Health Haemovigilance Department. An online reporting system at national level is in progress, probably will be in operation by 2018. Dr Yuce Ayhan Dr Behcet Uz Children's Hospital, Transfusion Center, Izmir, Turkey
  23. ISBT Monthly Webinar proposals for topics

    Based on findings from our clinical pilot study we belive that cold stored platelets could improve treatment of patients with critical bleeding (ref presentation at the ISBT Copenhagen). We would like more people to be involved in this discussion. Could this be a subject for a webinar?
  24. Getting to know each other

    hello Judith, I am happy to be in the ISBT family. i am interested in TTIs screening of blood donor and component separation. In Nepal, we do screening for HIV,HBV,HCV and SYPHILIS in blood donors . I like to work on other blood transmitted infections like Cytomegalovirus ,HTLV, Hepatitis A and E and other blood transmitted infections. we separate red cell concentrate, PRP, FFP and cryoprecipitate in our hospital. we have till now not used the methods like leucoreduction and irridiation and apheresis so i like to know more about them and like to implement those techniques in our hospital. thank you for suggesting the ISBT webinar. i will certainly go through them.
  25. Minutes of London and Dubai

    Dear members of the working party Donors & Donation, The minutes of our meetings in London and Dubai are uploaded in our working party section on the ISBT website. Peter van den Burg
  1. Load more activity